| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1From the Department of Optometry, University of Bradford, Bradford, United Kingdom; and the 2School of Education, Flinders University of South Australia, Bedford Park, South Australia, Australia.
PURPOSE. The Activities of Daily Vision Scale (ADVS) has been extensively validated by traditional methodology. In the current study, Rasch analysis was used to explore further the validity of the ADVS and to determine whether improvements could be made.
METHODS. Forty-three patients with cataract underwent visual acuity (VA) and contrast sensitivity (CS) testing and completed the ADVS. The data were Rasch analyzed and the value of response scale and item reduction explored. A shortened version and the original ADVS were tested for criterion validity by determining correlations with VA and CS.
RESULTS. The ADVS data contained nonnormally distributed items and items with ceiling effects and empty response categories. Therefore, items benefited from shortening the response scale, the optimum length being three responses. There was poor targeting of item difficulty to patient ability, because many patients with cataract were sufficiently able that they had no difficulty with many activities. Items were eliminated if the task was too easy or did not fit with the overall concept of visual disability determined by the Rasch model. A reduced ADVS version was established that had adequate precision, equivalent criterion validity, and improved targeting of item difficulty to patient ability, but this version was still not ideal.
CONCLUSIONS. Despite careful traditional validation, the ADVS data contained inadequacies exposed by Rasch analysis. Through Rasch scaling, particularly with response scale reduction, the ADVS can be improved, but additional questions seem to be needed to suit the more able, including patients undergoing second eye cataract surgery. There remains a need to develop Rasch-scaled measures of visual disability for use in ophthalmic outcomes research.
This article has been cited by other articles:
|
|
 |
|
  R. d. Toit, A. Palagyi, J. Ramke, G. Brian, and E. L. Lamoureux Development and Validation of a Vision-Specific Quality-of-Life Questionnaire for Timor-Leste Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4284 - 4289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Johnson and P. J. Murphy Measurement of Ocular Surface Irritation on a Linear Interval Scale with the Ocular Comfort Index Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4451 - 4458. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Denny, A. H. Marshall, M. R. Stevenson, P. M. Hart, and U. Chakravarthy Rasch Analysis of the Daily Living Tasks Dependent on Vision (DLTV) Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1976 - 1982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Lamoureux, J. F. Pallant, K. Pesudovs, G. Rees, J. B. Hassell, and J. E. Keeffe The Impact of Vision Impairment Questionnaire: An Assessment of Its Domain Structure Using Confirmatory Factor Analysis and Rasch Analysis Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1001 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Lamoureux, J. F. Pallant, K. Pesudovs, J. B. Hassell, and J. E. Keeffe The Impact of Vision Impairment Questionnaire: An Evaluation of Its Measurement Properties using Rasch Analysis Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4732 - 4741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Pesudovs, E. Garamendi, and D. B. Elliott The Contact Lens Impact on Quality of Life (CLIQ) Questionnaire: Development and Validation. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2789 - 2796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Subramanian and C. Dickinson Spatial Localization in Visual Impairment Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 78 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Smith, C. M. Dickinson, I. Cacho, B. C. Reeves, and R. A. Harper A Randomized Controlled Trial to Determine the Effectiveness of Prism Spectacles for Patients With Age-Related Macular Degeneration Arch Ophthalmol, August 1, 2005; 123(8): 1042 - 1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Stelmack, J. P. Szlyk, T. R. Stelmack, P. Demers-Turco, R. T. Williams, D. Moran, and R. W. Massof Psychometric Properties of the Veterans Affairs Low-Vision Visual Functioning Questionnaire Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3919 - 3928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Nutheti, B. R. Shamanna, S. Krishnaiah, V. K. Gothwal, R. Thomas, and G. N. Rao Perceived Visual Ability for Functional Vision Performance among Persons with Low Vision in the Indian State of Andhra Pradesh Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3458 - 3465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B A Noble, R S K Loh, S MacLennan, K Pesudovs, A Reynolds, L R Bridges, J Burr, O Stewart, and S Quereshi Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease Br. J. Ophthalmol., May 1, 2004; 88(5): 647 - 652. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
